Metsä Board Corporation’s operating result excluding

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Metsä Board Corporation’s operating result excluding non-recurring items for the first half of 2014 was EUR 64.4 million

Metsä Board Corporation Interim Report 1 January–30 June 2014, 31 July 2014 at 12:00 noon

Result for the first half of 2014

• Sales were EUR 995.2 million (Q1–Q2/2013: 1,037.8).

• Operating result excluding non-recurring items was EUR 64.4 million (56.2). Operating result including non-recurring items was EUR 75.7 million (63.7).

• Result before taxes excluding non-recurring items was EUR 40.8 million (22.4). Result before taxes including non-recurring items was EUR 49.9 million (29.8).

• Earnings per share excluding non-recurring items were EUR 0.10 (0.06). Earnings per share including non-recurring items were EUR 0.13 (0.08).

Result for the second quarter of 2014

• Sales were EUR 494.0 million (Q1/2014: 501.2).

• Operating result excluding non-recurring items was EUR 28.3 million (36.1). Operating result including non-recurring items was EUR 32.2 million (43.5).

• Result before taxes excluding non-recurring items was EUR 20.0 million (20.8). Result before taxes including non-recurring items was EUR 23.9 million (26.0).

• Earnings per share excluding non-recurring items were EUR 0.04 (0.06). Earnings per share including non-recurring items were EUR 0.05 (0.08).

Events during the second quarter of 2014

• Paperboard delivery volume increased compared to the previous quarter.

• Paper delivery volume decreased.

• Average market price levels for Metsä Board’s main products remained unchanged.

• Cash flow improved mainly due to reduced working capital, and net debt decreased considerably.

• Mika Joukio was appointed as the new CEO of Metsä Board as of 1 December 2014 at the latest, when Mikko Helander, the current CEO, will leave Metsä Board.

“Our paperboard deliveries continued to grow as planned in the second quarter, increasing by 7 per cent compared to the corresponding period last year. In line with our goals, North America recorded the highest growth rate. The sales volumes of our fresh forest fibre linerboard have increased steadily in North America, and our lightweight folding boxboards have been very well received.

In the second quarter, the result was burdened by scheduled maintenance shutdowns at the Husum integrated paper and pulp mill and Metsä Fibre’s Joutseno and Äänekoski mills, which were implemented successfully. Overall profitability in the second quarter was in line with our expectations, and our net debt decreased to EUR 540 million at the end of the second quarter thanks to our strong cash flow.

We successfully launched several new products: Carta Dedica, a lightweight board developed for food service and cup stock; Carta Allura for luxury packaging; and Modo Northern Light Coated, the newest linerboard product from Husum. These new products are excellent complements to Metsä Board’s existing product range.

Our paperboard order inflows have continued to strengthen recently, and we believe our paperboard deliveries will continue to increase in the third quarter.”

Mikko Helander, CEO

KEY FIGURES

  2014 2014 2013 2013 2014 2013 2013
  Q2 Q1 Q2 Q1 Q1-Q2 Q1-Q2 Q1-Q4
Sales, EUR million 494.0 501.2 502.8 535.0 995.2 1,037.8 2,019.3
EBITDA, EUR million 55.9 69.2 52.7 61.4 125.1 114.1 214.8
  excl. non-recurring items, EUR million 52.0 61.8 52.1 56.8 113.8 108.9 208.0
EBITDA, % 11.3 13.8 10.5 11.5 12.6 11.0 10.6
  excl. non-recurring items, % 10.5 12.3 10.4 10.6 11.4 10.5 10.3
Operating result, EUR million 32.2 43.5 28.9 34.8 75.7 63.7 113.6
  excl. non-recurring items, EUR million 28.3 36.1 26.0 30.2 64.4 56.2 104.4
EBIT, % 6.5 8.7 5.7 6.5 7.6 6.1 5.6
  excl. non-recurring items, % 5.7 7.2 5.2 5.6 6.5 5.4 5.2
Result before taxes, EUR million 23.9 26.0 21.3 8.5 49.9 29.8 57.8
  excl. non-recurring items, EUR million 20.0 20.8 18.5 3.9 40.8 22.4 48.6
Result for the period, EUR million 16.8 24.8 17.6 8.0 41.6 25.6 64.1
  excl. non-recurring items, EUR million 12.9 20.6 15.3 3.4 33.5 18.7 55.4
Result per share, EUR 0.05 0.08 0.06 0.02 0.13 0.08 0.19
  excl. non-recurring items, EUR 0.04 0.06 0.05 0.01 0.10 0.06 0.17
Return on equity, % 8.0 11.6 8.5 3.8 9.9 6.1 7.5
  excl. non-recurring items, % 6.1 9.6 7.4 1.6 8.0 4.5 6.5
Return on capital employed, % 8.5 11.2 6.7 7.7 10.0 7.1 7.0
  excl. non-recurring items, % 7.5 9.9 6.1 6.8 8.8 6.3 6.4
Equity ratio at end of period, % 39.8 41.0 32.4 33.3 39.8 32.4 40.7
Gearing ratio at end of period, % 84 84 130 122 84 130 83
Net gearing ratio at end of period, % 65 69 74 69 65 74 70
Shareholders' equity per share at
end of period, EUR
2.54 2.62 2.48 2.54 2.54 2.48 2.59
Interest-bearing net liabilities, EUR million 540.1 592.6 605.9 577.6 540.1 605.9 597.2
Gross investments, EUR million 14.0 4.7 21.5 9.2 18.7 30.7 66.9
Deliveries, 1 000 tonnes              
  Cartonboard 226 219 220 217 445 437 872
  Linerboard and Paper 250 265 250 279 515 529 1,027
Personnel at the end of period 3,370 3,145 3,401 3,239 3,370 3,401 3,116
               
EBITDA = Earnings before interest, taxes, depreciation and impairment charges

The divestment of the holding in Metsä Group Treasury Oy in September 2013 improved Metsä Board’s equity ratio by approximately 5 percentage points and return on capital employed by almost 1 percentage point and reduced the company’s gross debt by more than EUR 300 million, compared to the actual figures for the second quarter of 2013.

Business environment and near-term outlook

Compared to the second quarter, the delivery volumes of folding boxboard and white-top fresh forest fibre linerboard are estimated to increase slightly in the third quarter of 2014. No material price changes are in sight at the moment.

The delivery volumes of uncoated fine paper, coated papers and market pulp in the third quarter of 2014 are expected to remain at approximately the same level as in the previous quarter. No material changes in the price of paper are in sight. The average price of Metsä Board’s market pulp deliveries is also expected to be stable over the next few months.

The annual maintenance shutdown at the Kemi integrated mill will have some negative impact in the third quarter of 2014.

Production costs in the third quarter of 2014 are expected to be approximately at the same level as in the previous quarter.

Metsä Board’s operating result, excluding non-recurring items is in the third quarter of 2014 expected to improve slightly from the second quarter of 2014.

Disclosure procedure

Metsä Board Corporation follows the disclosure procedure enabled by Standard 5.2b published by the Finnish Financial Supervision Authority and hereby publishes its Interim Report for January–June 2014 enclosed to this stock exchange release. Metsä Board's complete Financial Statements is attached to this release in pdf-format and is also available on the company's web site at www.metsaboard.com.

METSÄ BOARD CORPORATION

More information:

Markus Holm, CFO, tel. +358 (0)10 465 4913

Juha Laine, Vice President, Investor Relations and Communications, tel. +358 (0)10 465 4335

More information will be available from 1 p.m. on 31 July 2014. A conference call for investors and analysts will be held in English at 3 p.m. (EET). Conference call participants are requested to dial in and register a few minutes earlier on the following numbers:

Europe: +44 (0)20 7162 0025

USA: +1 334 323 6201

The conference ID is 945666.

Metsä Board is Europe’s leading producer of folding boxboard, the world’s leading manufacturer of coated white-top fresh forest fibre kraftliners and a major paper supplier. It offers premium solutions for consumer and retail packaging, graphics and office end-uses. The company’s sales network serves brand owners, carton printers, corrugated packaging manufacturers, printers, merchants and office suppliers. Metsä Board is part of Metsä Group and its shares are listed on the NASDAQ OMX Helsinki. In 2013, the company’s sales totalled approximately EUR 2.0 billion. The company has approximately 3,100 employees.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Acumen Pharmaceuticals to Showcase Innovations at Conference

Updated Category News Views 115

Acumen Pharmaceuticals to Present at Health Conference Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering clinical-stage biopharmaceutical company, is set to engage in a significant fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. This event will happen shortly, providing a platform for Acumen to discuss their innovative approaches to tackling...

Continue Reading
Chanson International Holding Reports Fiscal Year 2025 Mid-Year Results

Updated Category News Views 192

Chanson International Holding Reports Mid-Year Financial Results Chanson International Holding (NASDAQ: CHSN) has recently unveiled its financial performance for the first half of the fiscal year 2025. As a key player in the bakery and beverage sectors, the company's unaudited results signify its resilience in a fluctuating market. Overview of Financial Performance...

Continue Reading
Investors Are Strategically Analyzing REGN Options Activity

Updated Category News Views 66

Examining Recent Changes in REGN Options There's been a noteworthy shift in sentiment among financial experts regarding Regeneron Pharmaceuticals. A recent analysis of the trading patterns in REGN options has revealed a blend of bullish and bearish movements in the market. This information serves as a foundation for understanding the current factors that are shaping...

Continue Reading
Analysts Raise Price Targets for CVS After Strong Earning Report

Updated Category News Views 99

CVS Health Exceeds Expectations with Recent Earnings CVS Health Corp (NYSE: CVS) delivered an impressive earnings report for its fourth quarter, showing robust sales numbers that surpassed analysts' expectations. The company announced fourth-quarter sales totaling an incredible $97.71 billion, outpacing the consensus estimate of $97.19 billion. Adjusted Earnings Report...

Continue Reading
Healthcare Triangle and Teyame AI Join Forces to Innovate Patient Engagement

Updated Category News Views 161

Healthcare Triangle Announces Strategic Partnership with Teyame AI Healthcare Triangle, Inc. (Nasdaq: HCTI) is excited to share its recent agreement with Teyame AI LLC, a visionary corporation aiming to revolutionize customer experience through artificial intelligence. This partnership is a transformative step that will not only enhance HCTI's SaaS capabilities but is...

Continue Reading